Overview

A Study to Assess the Bioequivalence of Famotidine/Antacid Combination Tablets Compared to Famotidine/Antacid EZ Chew Tablets (0208C-145)(COMPLETED)

Status:
Completed

Trial end date:
2008-03-01

Target enrollment:

Participant gender:

Summary

A study in 24 healthy subjects to assess the bioequivalence of Famotidine/Antacid EZ Chew tablet taken without water and with water compared to the Famotidine/Antacid tablet taken with water. Subjects will be given a single dose of each treatment separated by 5 to 7 days.

Phase:

Phase 1

Details

Lead Sponsor:

Johnson & Johnson Consumer and Personal Products Worldwide

Treatments:

Antacids
Anti-Ulcer Agents
Calcium
Calcium Carbonate
Calcium, Dietary
Famotidine
Magnesium Hydroxide